Government Initiatives Have A Significant Impact On The HIV Drugs Market

HIV Drugs Market 2021 - Opportunities And Strategies – Forecast To 2030

HIV Drugs Market 2021 – Opportunities And Strategies – Global Forecast To 2030

The Business Research Company’s HIV Drugs Market 2021 – Opportunities And Strategies – Global Forecast To 2030

LONDON, GREATER LONDON, UK, November 22, 2021 / — Government initiatives and efforts towards implementing reforms have had a significant impact on the market, in both developed and developing countries. For instance, the Health Resources and Services Administration’s (HRSA) Bureau of Primary Health Care announced the availability of around $83 million for up to 300 health centers for the fiscal year 2021 Ending the HIV Epidemic- Primary Care HIV Prevention (PCHP) program. The PCHP funding is likely to expand HIV prevention services with the motive of decreasing the risk of HIV transmission across 57 geographic locations recognized by Ending the HIV Epidemic: A Plan for America. Additionally, in December 2020, the fiscal year budget passed included $386 million for the implementation of the EHE initiative along with $175 million for the Centers for Disease Control and Prevention (CDC) to reduce new HIV infections. Therefore, these government initiatives push the development of HIV drug demand and thereby contributing to the growth of the market in the forecast period.

TBRC’s holiday sale has begun with discounts on ALL market research reports! Grab your deal now.

The global HIV drugs market size reached a value of nearly $30.52 billion in 2020, having increased at a compound annual growth rate (CAGR) of 8.1% since 2015. The HIV drugs market is expected to grow from $30.52 billion in 2020 to $36.46 billion in 2025 at a rate of 3.6%. The growth of the HIV drugs market is mainly due to the growing prevalence of HIV and government initiatives which is expected to drive the demand for HIV drugs. The HIV drugs market is expected to grow from $36.46 billion in 2025 to $40.30 billion in 2030 at a CAGR of 2.0%.

Read More On The Global HIV Drugs Market Report:

HIV drug manufacturing companies are increasingly adopting 3D bioprinting technology in the development and manufacturing processes of HIV drugs to reduce manufacturing costs and increase production efficiencies and expedite the process of drug discovery. 3D bioprinting is a manufacturing process where a 3D structure of the tissue is created using bio-ink. Bio-inks are materials which are used to produce artificial live tissues using 3D printing. For instance, Viiv Healthcare Limited, a USA-based pharmaceutical company specializing in developing HIV therapies is using HP’s D300 for creating latency reversal drugs for HIV. Moreover, companies are continuously manufacturing 3D bioprinters for overcoming technical limitations plaguing pharmaceutical research, regenerative medicine, and tissue engineering. For example, in December 2020, mimiX Biotherapeutics, a biotechnology company launched cymatiX, the company’s first acoustic bioprinter intended for an affordable and fast method of fabricating multi-cellular tissue constructs.

Major players covered in the global HIV drugs market are Gilead Sciences, Inc, GlaxoSmithKline plc., Johnson & Johnson, Merck & Co., Inc., Boehringer Ingelheim International GmbH.

TBRC’s global HIV drugs market report is segmented by type into nucleoside reverse transcriptase inhibitors (NRTS), non- nucleoside reverse transcriptase inhibitors (NNRTS), protease inhibitors, integrate inhibitors, fusion inhibitors, chemokine receptor inhibitors, others, by application into hospital pharmacies, retail pharmacies, online pharmacies, others, by administration into oral, parenteral.

HIV Drugs Market 2021 – By Type (Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrase strand transfer inhibitors (INSTIs)) By Application (Hospital Pharmacies, Retail Pharmacies) By Administration (Oral, Parenteral) And By Region, Opportunities And Strategies – Global Forecast To 2030 is one of a series of new reports from The Business Research Company that provides HIV drugs market overview, forecast HIV drugs market size and growth for the whole HIV drugs market, HIV drugs market segments, and geographies, HIV drugs market trends, HIV drugs market drivers, restraints, leading competitors’ revenues, profiles, and HIV drugs market shares.

Request For A Sample Of The Global HIV Drugs Market Report:

Here Is A List Of Similar Reports By The Business Research Company:

Drugs For Hormonal Replacement Therapy Global Market Report 2021 – By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Menopause), By Route of Administration (Oral, Parental), COVID-19 Impact and Recovery

Drugs For Benign Prostatic Hypertrophy Global Market Report 2021 – By Type (Alpha Blocker, 5-alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor), By End User (Hospital Pharmacies, Retail Pharmacies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), COVID-19 Impact And Recovery

Vaccines Market 2021 – By Type (Anti-Infective Vaccines, Anti-Cancer Vaccines, Others), By Technology (Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Other Technologies), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Other Route of Administration), By Valance (Monovalent, Multivalent), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales), And By Region, Opportunities And Strategies – Global Forecast To 2030

Interested to know more about The Business Research Company?
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Read more about us at

Or get a quick glimpse of our services here:

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Follow us on LinkedIn:
Follow us on Twitter:
Check out our Blog:

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media:

Leave a Reply

Your email address will not be published. Required fields are marked *